Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

BACKGROUND: The Adjuvant Chemotherapy Trial of TS-1 for Colon Cancer (ACTS-CC) is a phase III trial designed to validate the non-inferiority of S-1 to UFT/leucovorin (LV) as postoperative adjuvant chemotherapy for stage III colon cancer. We report the results of a planned safety analysis. METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales: Mochizuki, I, Takiuchi, H, Ikejiri, K, Nakamoto, Y, Kinugasa, Y, Takagane, A, Endo, T, Shinozaki, H, Takii, Y, Takahashi, Y, Mochizuki, H, Kotake, K, Kameoka, S, Takahashi, K, Watanabe, T, Watanabe, M, Boku, N, Tomita, N, Matsubara, Y, Sugihara, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314794/
https://www.ncbi.nlm.nih.gov/pubmed/22415232
http://dx.doi.org/10.1038/bjc.2012.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314794/
https://www.ncbi.nlm.nih.gov/pubmed/22415232
http://dx.doi.org/10.1038/bjc.2012.86

Ejemplares similares